跳至主要内容
临床试验/NCT06727292
NCT06727292招募中不适用

Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo

Finzelberg GmbH & Co. KG2 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2024年10月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
66
试验地点
2
主要终点
Skin Physiological Parameters

研究概览

简要总结

The purpose of this clinical trial is to evaluate whether nutritional supplementation over a 2-month period improves skin physiological parameters. This is a national, single-center, double-blind, randomized pilot study.

The study will be conducted using a supplement and a placebo, the safety of which has been assured by the sponsor.

Participants will:

  • Take a food supplement or a placebo once daily for 2 months
  • Visit the study center at beginning, after 28 days and after 56 days of supplementation.
  • Keep a diary of their skin status and tolerability

The secondary objective is to evaluate product characteristics and performance during normal use in healthy subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

the product is also masked

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Phototype: I to IV;
  • Subjects with normal to dry skin;
  • Subjects with healthy skin on the study area;
  • Non-smokers;
  • Has normal nutritional habits (not vegetarian/vegan);
  • Is not pregnant or lactating;
  • Has a BMI of 18 - 33 kg/m2;
  • Is willing to refrain from taking dietary supplements (at best not at all, in any case not during the last month before study start);
  • Willing not to use any oral products or any nutritional supplementation aiming at improving skin status during the course of the study;
  • No history of malabsorption diseases, liver diseases, or diseases of the lipid metabolism;
  • Uses no medication, which may interact with the study product

排除标准

  • For women: pregnant or nursing woman or woman planning to get pregnant during the study;
  • Cutaneous pathology on the study zone (eczema, etc.);
  • Subject with make-up on the day of the visit at the laboratory;
  • Use of topical or systemic treatment during the previous weeks liable to interfere with the assessment of the efficacy of the study product:
  • change in anti-wrinkle, smoothing and/or firming topical products within previous week on the studied zones,
  • non-invasive procedures within previous month on the studied zones,
  • intake of food supplement acting on skin within the three previous months,
  • invasive procedures:
  • deep chemical peeling within previous 3 months on the studied zones,
  • mesotherapy, dermapen, laser within previous 6 months on the studied zones,
  • botox and/or hyaluronic acid injections within previous 12 months on the studied zones;
  • Intake of vitamin substances and diets comprising a change of normal eating habits;
  • Known allergy to one or several investigational product´s ingredients;
  • Participation in a nutritional study within the last 30 days;
  • Surgical or internal diseases e.g. a metabolic or endocrine disease that may affect the outcome of the study (e.g. diabetes, liver diseases, kidney disorders) or having a history of medical or surgical events that may significantly affect the study outcome including any cardiovascular disease, skin disease, hypertension (>140/90 mm Hg in three repeated measurements).

结局指标

主要结局

Skin Physiological Parameters

时间窗: Skin physiological parameters will be assessed at Day 0, Day 28, Day 56

Changes in skin hydration: Measurement of skin hydration by means of a Corneometer CM825.

次要结局

  • Subject satisfaction(It will be assessed at Day 28, Day 56)
  • Adverse events(Adverse events will be assessed during the whole study from Day 0 to Day 56)
  • Subject self-assessment quality of the skin and hair.(It will be assessed at Day 28, Day 56)

研究者

发起方
Finzelberg GmbH & Co. KG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验